Publications

  • Why "Episodes" Matter for Doctors

    May 23, 2018 | Forbes.com

    A customer "episode" is a key unit of management that can produce significant growth and cost savings.

  • The Cure for Pharma's Commercial Productivity Woes

    May 09, 2018 | Bain Brief

    To earn greater loyalty and raise productivity, figure out what really matters for doctors.

  • A Path to Faster Growth for Healthcare Companies: Eliminate Complexity

    November 08, 2017 | Bain Brief

    Healthcare manufacturers have long believed that all revenue growth is good. But to increase the top line, many launched new products without addressing legacy versions, entered new categories without a path to leadership and expanded to all corners of the world without sufficient local scale.

  • How to Make Your Drug Launch A Success

    October 23, 2017 | IN VIVO

    The pain is becoming all too common for many pharmaceutical executives. After a decade or more of investment in drug development and clinical trials, a company launches a promising new product only to see sales fall far short of expectations.

  • Why Leading Medtech Companies Are Putting Customers Ahead of Products

    September 07, 2017 | Bain Brief

    The leadership team at a global technology company had to move fast. Its products were losing market share as customers switched to integrated solutions. Worse, clients cited the company’s lack of responsiveness as a main reason for switching.

  • How to Make Your Drug Launch a Success

    September 06, 2017 | Pharmaceuticals | Bain Brief

    Bain research shows successful pharmaceutical companies are overhauling their approach to drug launch—and they do three things right.

  • Finding The Right Path To Category Leadership In Oncology

    June 03, 2017 | IN VIVO

    Oncology drug development is undergoing rapid shifts. Bain research shows companies that seek to lead in specific vertical categories outperform rivals that invest across a broad spectrum of cancer targets.

  • Focus Matters: How Biopharma Can Reward Shareholders

    November 30, 2016 | Bain Brief

    Why do the largest companies struggle to deliver above-average shareholder returns? And more important, what can they do to lift a stubbornly low TSR? The short answer: Avoid complex, wide-ranging portfolios that undermine focus.

  • US Election Bulletin: Implications for Healthcare

    November 10, 2016 | Bain Brief

    The election of a Republican president, combined with Republican control of both houses of Congress, has the potential to reshape the healthcare market landscape.

  • Finding the Path to Category Leadership in Oncology

    September 28, 2016 | Bain Brief

    Combination therapies are poised to transform markets over the next decade. Companies that use a category leadership approach and focus on one or two oncology fields will outperform rivals.